Prognostic Value of Delirium in Patients With Acute Heart Failure in the Intensive Care Unit.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 08 2019
revised: 07 01 2020
accepted: 10 01 2020
pubmed: 3 7 2020
medline: 20 5 2021
entrez: 3 7 2020
Statut: ppublish

Résumé

Delirium is a common adverse event observed in patients admitted to the intensive care unit (ICU). However, the prognostic value of delirium and its determinants have not been thoroughly investigated in patients with acute heart failure (AHF). We investigated 408 consecutive patients with AHF admitted to the ICU. Delirium was diagnosed by means of the Confusion Assessment Method for ICU tool and evaluated every 8 hours during the patients' ICU stays. Delirium occurred in 109 patients (26.7%), and the in-hospital mortality rate was significantly higher in patients with delirium (13.8% vs 2.3%; P < 0.001). Multivariate logistic regression analysis showed that delirium independently predicted in-hospital mortality (odds ratio [OR] 4.33, confidence interval [CI] 1.62-11.52; P = 0.003). Kaplan-Meier analysis showed that the 12-month mortality rate was significantly higher in patients with delirium compared with those without (log-rank test: P < 0.001), and Cox proportional hazards analysis showed that delirium remained an independent predictor of 12-month mortality (hazard ratio 2.19, 95% CI 1.49-3.25; P < 0.001). The incidence of delirium correlated with severity of heart failure as assessed by means of the Get With The Guidelines-Heart Failure risk score (chi-square test: P = 0.003). Age (OR 1.05, 95% CI 1.02-1.09; P = 0.003), nursing home residential status (OR 3.32, 95% CI 1.59-6.94; P = 0.001), and dementia (OR 5.32, 95% CI 2.83-10.00; P < 0.001) were independently associated with the development of delirium. Development of delirium during ICU stay is associated with short- and long-term mortality and is predicted by the severity of heart failure, nursing home residential, and dementia status.

Sections du résumé

BACKGROUND
Delirium is a common adverse event observed in patients admitted to the intensive care unit (ICU). However, the prognostic value of delirium and its determinants have not been thoroughly investigated in patients with acute heart failure (AHF).
METHODS
We investigated 408 consecutive patients with AHF admitted to the ICU. Delirium was diagnosed by means of the Confusion Assessment Method for ICU tool and evaluated every 8 hours during the patients' ICU stays.
RESULTS
Delirium occurred in 109 patients (26.7%), and the in-hospital mortality rate was significantly higher in patients with delirium (13.8% vs 2.3%; P < 0.001). Multivariate logistic regression analysis showed that delirium independently predicted in-hospital mortality (odds ratio [OR] 4.33, confidence interval [CI] 1.62-11.52; P = 0.003). Kaplan-Meier analysis showed that the 12-month mortality rate was significantly higher in patients with delirium compared with those without (log-rank test: P < 0.001), and Cox proportional hazards analysis showed that delirium remained an independent predictor of 12-month mortality (hazard ratio 2.19, 95% CI 1.49-3.25; P < 0.001). The incidence of delirium correlated with severity of heart failure as assessed by means of the Get With The Guidelines-Heart Failure risk score (chi-square test: P = 0.003). Age (OR 1.05, 95% CI 1.02-1.09; P = 0.003), nursing home residential status (OR 3.32, 95% CI 1.59-6.94; P = 0.001), and dementia (OR 5.32, 95% CI 2.83-10.00; P < 0.001) were independently associated with the development of delirium.
CONCLUSIONS
Development of delirium during ICU stay is associated with short- and long-term mortality and is predicted by the severity of heart failure, nursing home residential, and dementia status.

Identifiants

pubmed: 32615071
pii: S0828-282X(20)30039-8
doi: 10.1016/j.cjca.2020.01.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1649-1657

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Etsuo Iwata (E)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Toru Kondo (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: toru.k0927@med.nagoya-u.ac.jp.

Toshiaki Kato (T)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Takahiro Okumura (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Itsumure Nishiyama (I)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Shingo Kazama (S)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Toshikazu Ishihara (T)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Sayano Kondo (S)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Hiroaki Hiraiwa (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Takuma Tsuda (T)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Masanori Ito (M)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Morihiko Aoyama (M)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Daisuke Tanimura (D)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Yoshifumi Awaji (Y)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Aichi, Japan.

Kazumasa Unno (K)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH